Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Sep;27(5):249-250.
doi: 10.1136/ejhpharm-2019-002134. Epub 2019 Dec 2.

Oncology workforce skills and competencies required for molecular medicine

Emma Groves  1
Affiliations
Editorial

Oncology workforce skills and competencies required for molecular medicine

Emma Groves. Eur J Hosp Pharm. 2020 Sep.
No abstract available

Keywords: health workforce; molecular medicine; pharmacogenomic variants; precision medicine.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Overview of patient consent to treatment stratification workflow. Following patient consent, the tumour sample is assessed by a pathologist. This is then followed by DNA extraction and NGS sequencing. Bioinformatical data analysis is followed by data curation and validation of molecular targets. The resulting molecular alterations are then evaluated and reviewed at the GTAB meeting and treatment options for the patient determined. The outcome of the GTAB meeting is then reported to the relevant clinicians, the wider multidisciplinary team and the patient. Figure 1 was modified with permission from Horak et al.
See this image and copyright information in PMC

References

    1. Wetterstrand KA. DNA sequencing costs: data from the NHGRI genome sequencing program (GSP), 2019. Available: https://www.genome.gov/sequencingcostsdata [Accessed Oct 2019].
    1. Leonetti A, Facchinetti F, Rossi G, et al. . BRAF in non-small cell lung cancer (NSCLC): pickaxing another brick in the wall. Cancer Treat Rev 2018;66:82–94. 10.1016/j.ctrv.2018.04.006 - DOI - PubMed
    1. Royal College of Physicians, Royal College of Pathologists and British Society for Genetic Medicine Consent and confidentiality in genomic medicine: guidance on the use of genetic and genomic information in the clinic. 3rd edn Report of the Joint Committee on Genomics in Medicine, 2019. https://www.bsgm.org.uk/media/11527/consent_confidentiality_working_repo...
    1. Massard C, Michiels S, Ferté C, et al. . High-throughput genomics and clinical outcome in hard-to-treat advanced cancers: results of the Moscato 01 trial. Cancer Discov 2017;7:586–95. 10.1158/2159-8290.CD-16-1396 - DOI - PubMed
    1. Horak P, Fröhling S, Glimm H. Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls. ESMO Open 2016;1:e000094 10.1136/esmoopen-2016-000094 - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources